The disclosed invention generally relates to treatment and/or prevention of symptoms associated with cannabinoid responsive diseases and disorders in subjects in need thereof, as well as the method of administering therapeutically-effective amount of a pharmaceutical compound containing cannabinoids. The disclosed invention further relates to pharmaceutical compounds for treating and/or preventing symptoms associated with said diseases and disorders.
所公开的发明一般涉及治疗和/或预防有需要的受试者中与
大麻素反应性疾病和紊乱相关的症状,以及施用治疗有效量的含
大麻素的药用化合物的方法。本发明还涉及用于治疗和/或预防上述疾病和紊乱相关症状的药物化合物。